Checkpoint Therapeutics Stock Income Statements

Checkpoint Therapeutics Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

Checkpoint Therapeutics Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
revenue	6,000	31,000	31,000	35,000	74,000	48,000	18,000	52,000	16,000	29,000	155,000	68,000	27,000	28,000	42,000	972,000	25,000	280,000	1,051,000	352,000	3,031,000	5,000	127,000	343,000	332,000	349,000	351,000	693,000	498,000	546,000	1,249,000	277,000	65,000	25,000
cost of revenue	0	0	13,945,000	15,826,000	14,236,000	8,866,000	12,053,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
gross profit	6,000	31,000	-13,914,000	-15,791,000	-14,162,000	-8,818,000	-12,035,000	52,000	16,000	29,000	155,000	68,000	27,000	28,000	42,000	972,000	25,000	280,000	1,051,000	352,000	3,031,000	5,000	127,000	343,000	332,000	349,000	351,000	693,000	498,000	546,000	1,249,000	277,000	65,000	25,000
operating expenses
research and development	8,298,999	5,496,000	13,945,000	15,826,000	14,236,000	8,866,000	12,053,000	14,670,000	27,658,000	9,384,000	7,198,000	4,213,000	8,145,000	2,543,000	3,029,000	2,635,000	6,730,000	3,894,000	4,120,000	4,581,000	13,421,000	7,848,000	5,453,000	6,932,000	4,916,000	4,955,000	5,506,000	3,704,000	7,743,000	4,713,000	5,446,000	2,365,000	5,359,000	3,485,000
sales, general and administrative
total operating expenses	10,175,000	7,732,000	16,226,000	18,118,000	16,718,000	10,712,000	14,182,000	16,913,000	29,786,000	11,307,000	9,312,000	6,586,000	10,269,000	4,972,000	4,716,000	4,313,000	8,882,000	5,514,000	5,878,000	6,284,000	14,923,000	9,392,000	6,805,000	9,126,000	6,271,000	6,299,000	6,823,000	5,107,000	8,833,000	5,685,000	6,667,000	3,549,000	7,515,000	3,704,000
operating income	-10,169,000	-7,701,000	-16,195,000	-18,083,000	-16,644,000	-10,664,000	-14,164,000	-16,835,000	-29,770,000	-11,278,000	-9,157,000	-6,518,000	-10,242,000	-4,944,000	-4,674,000	-3,341,000	-8,857,000	-5,234,000	-4,827,000	-5,932,000	-11,892,000	-9,387,000	-6,678,000	-8,783,000	-5,939,000	-5,950,000	-6,472,000	-4,414,000	-8,335,000	-5,139,000	-5,418,000	-3,272,000	-7,450,000	-3,679,000
net income	-19,128,000	-5,724,000	-16,521,000	-2,865,000	-25,365,000	-10,508,000	-14,098,000	-16,822,000	-29,756,000	-11,265,000	-9,144,000	-6,505,000	-10,225,000	-4,930,000	-4,645,000	-3,281,000	-8,826,000	-5,206,000	-4,792,000	-5,890,000	-11,619,000	-9,344,000	-6,639,000	-8,765,000	-5,918,000	-5,928,000	-6,448,000	-4,383,000	-8,323,000	-5,128,000	-5,405,000	-3,605,000	-8,051,000	-3,749,000

We provide you with 20 years income statements for Checkpoint Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Checkpoint Therapeutics stock. Explore the full financial landscape of Checkpoint Therapeutics stock with our expertly curated income statements.

The information provided in this report about Checkpoint Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.